Antibiofilm activity of host defence peptides: Complexity provides opportunities
Host defence peptides (HDPs) are integral components of innate immunity across all living
organisms. These peptides can exert direct antibacterial effects, targeting planktonic cells …
organisms. These peptides can exert direct antibacterial effects, targeting planktonic cells …
[HTML][HTML] Lessons learned from clinical trials using antimicrobial peptides (AMPs)
GS Dijksteel, MMW Ulrich, E Middelkoop… - Frontiers in …, 2021 - frontiersin.org
Antimicrobial peptides (AMPs) or host defense peptides protect the host against various
pathogens such as yeast, fungi, viruses and bacteria. AMPs also display immunomodulatory …
pathogens such as yeast, fungi, viruses and bacteria. AMPs also display immunomodulatory …
Antibiotic resistance and the MRSA problem
Staphylococcus aureus is capable of becoming resistant to all classes of antibiotics clinically
available and resistance can develop through de novo mutations in chromosomal genes or …
available and resistance can develop through de novo mutations in chromosomal genes or …
The Continuing Threat of Methicillin-Resistant Staphylococcus aureus
M Gajdács - Antibiotics, 2019 - mdpi.com
Staphylococcus aureus has been an exceptionally successful pathogen, which is still
relevant in modern age-medicine due to its adaptability and tenacity. This bacterium may be …
relevant in modern age-medicine due to its adaptability and tenacity. This bacterium may be …
Self-assembling dipeptide antibacterial nanostructures with membrane disrupting activity
L Schnaider, S Brahmachari, NW Schmidt… - Nature …, 2017 - nature.com
Peptide-based supramolecular assemblies are a promising class of nanomaterials with
important biomedical applications, specifically in drug delivery and tissue regeneration …
important biomedical applications, specifically in drug delivery and tissue regeneration …
Alternatives to conventional antibiotics in the era of antimicrobial resistance
As more antibiotics are rendered ineffective by drug-resistant bacteria, focus must be shifted
towards alternative therapies for treating infections. Although several alternatives already …
towards alternative therapies for treating infections. Although several alternatives already …
[PDF][PDF] Antibacterial agents in clinical development: an analysis of the antibacterial clinical development pipeline, including tuberculosis
World Health Organization - 2017 - apps.who.int
The discovery of antibiotics has long been regarded as one of the most significant medical
achievements of the twentieth century. Antibiotics have saved millions of lives (1) and …
achievements of the twentieth century. Antibiotics have saved millions of lives (1) and …
[HTML][HTML] Antibiotics in late clinical development
P Fernandes, E Martens - Biochemical pharmacology, 2017 - Elsevier
Most pharmaceutical companies have stopped or have severely limited investments to
discover and develop new antibiotics to treat the increasing prevalence of infections caused …
discover and develop new antibiotics to treat the increasing prevalence of infections caused …
Development of Membrane-Active Honokiol/Magnolol Amphiphiles as Potent Antibacterial Agents against Methicillin-Resistant Staphylococcus aureus (MRSA)
Y Guo, E Hou, T Wen, X Yan, M Han… - Journal of Medicinal …, 2021 - ACS Publications
Currently, infections caused by drug-resistant bacteria have become a new challenge in anti-
infective treatment, seriously endangering public health. In our continuous effort to develop …
infective treatment, seriously endangering public health. In our continuous effort to develop …
Thinking outside the box—novel antibacterials to tackle the resistance crisis
M Lakemeyer, W Zhao, FA Mandl… - Angewandte Chemie …, 2018 - Wiley Online Library
The public view on antibiotics as reliable medicines changed when reports about “resistant
superbugs” appeared in the news. While reasons for this resistance development are easily …
superbugs” appeared in the news. While reasons for this resistance development are easily …